Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Total expenses | 193 | 168 | 156 | 288 | 1,279 |
| Operating Income | -193 | -168 | -156 | -288 | -1,279 |
| Interest Expense | 4 | 7 | 8 | 63 | 10 |
| Other Income | 0 | 0 | 0 | 0 | 7 |
| Pre-tax Income | -198 | -175 | -164 | -351 | -1,283 |
| Net Income Continuous | -198 | -175 | -164 | -351 | -1,283 |
| Net Income | $-198 | $-175 | $-164 | $-351 | $-1,283 |
| EBITDA(a) | $-190 | $-161 | $-151 | $-278 | $-1,271 |